2023 annual financial data
Lantern Pharma 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -17,877,570 USD and net income was -15,961,534 USD.
Operating cash flow was -14,346,548 USD.
Get free Lantern Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -17,877,570 USD
- Net income
- -15,961,534 USD
- Operating cash flow
- -14,346,548 USD